Trial Profile
Assessment of Protection Against Malaria by Sporozoite Challenge of Healthy Adults Vaccinated With the Virosomal Vaccine PEV3A and FP9-MVA ME-TRAP. A Phase I / IIa Controlled Challenge Trial
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Malaria DNA vaccine (Primary) ; Malaria vaccine (Primary)
- Indications Falciparum malaria
- Focus Pharmacodynamics; Registrational; Therapeutic Use
- 09 Jun 2008 New trial record.